Íslandsbanki - Bank bill (ISLA 16 0616) admitted to
Íslandsbanki - Bank bill (ISLA 16 0616) admitted to trading on 29 December 2015 | Term Sheet |
| Issuer: | Íslandsbanki hf. |
| Org. no: | 491008-0160 |
| Address: | Kirkjusandur 2, 155 Reykjavík |
| |
| Bonds/bills: | Bonds |
| Symbol (Ticker) | ISLA 16 0616 |
| ISIN code | IS0000026599 |
| CFI code | D-Y-Z-U-X-R |
| Registered at ISD | Yes |
| Amortization type | Zero coupon bond |
| Country | Iceland |
| Currency | ISK |
| Date of admission to trading | 29.12.2015 |
| Order book ID | 117591 |
| Instrument subtype | Corporate Bonds |
| Market | OMX ICE DP Fixed Income |
| List population name | OMX ICE Bank Bills |
| Denomination in CSD | 20,000,000 |
| Size limit | 5,000,000,000 which equals 250 denominations |
| Total issued amount | 860,000,000 |
| Amount admitted to trading at this time | 860,000,000 |
| Issue date | Tuesday, December 29, 2015 |
| First ordinary installment date | |
| Total number of installments | 1 |
| Installment frequency | 1 |
| Maturity date | Wednesday, June 29, 2016 |
| Interest rate | N/A |
| Floating interest rate | N/A |
| Premium | N/A |
| Simple/compound interest | Simple |
| Day count convention | Act/360 |
| Interest from date | |
| First ordinary coupon date | |
| Coupon frequency | N/A |
| Total number of coupon payments | N/A |
| Indexed | No |
| Name of index | N/A |
| Daily index or monthly index | NA |
| Base index value | N/A |
| Index base date | |
| Dirty price / clean price | N/A |
| Call option | Nei |
| Put option | Nei |
| Convertible | Nei |
| Additional information | Nei |
| Market making | Nei |
| Credit rating (rating agency, date) | Nei |
| Securities depository | Nasdaq Verðbréfamiðstöð hf. |
| Coordinator – admission to trading | Íslandsbanki hf. |
| If irregular cash flow, then how | N/A |
| If payment date is a bank holiday, does payment include accrued interest for days missing until next business day? | No |
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Overview of iBio’s Fiscal Year 2024 Financial Results iBio, Inc. (NYSEA:IBIO), a leader in biopharmaceuticals using AI technology, has recently shared its financial performance for the fiscal year that ended on June 30, 2024. The company is dedicated to developing antibody therapies for complex conditions, utilizing machine learning approaches to enhance their efforts....
Continue Reading
Exciting Developments for Atossa Therapeutics at Upcoming Symposium SEATTLE, November 2024 – Atossa Therapeutics, Inc. (NASDAQ: ATOS), a biopharmaceutical company known for its innovative approach in treating breast cancer, is gearing up to share groundbreaking research on (Z)-endoxifen at the upcoming San Antonio Breast Cancer Symposium (SABCS). This symposium is an...
Continue Reading
Exciting Announcement for Sports Fans at Live! Casino & Hotel DraftKings is thrilled to announce its role as the official sportsbook for the highly anticipated Live! Casino & Hotel, which boasts a remarkable investment of over $270 million. This venue is set to create waves in the sports entertainment scene. The grand opening is expected, and it promises to be a game...
Continue Reading
Transforming Learning Spaces with Collaborative Efforts In a remarkable initiative, School Specialty and the College Football Playoff Foundation are making strides in enhancing the educational landscape. Their recent accomplishment includes the makeover of a media center at North Dade Middle School, marking the 100th transformed learning environment as part of the Extra...
Continue Reading
Velvet Taco Introduces New Velvet Bowls to Excite Diners In an exciting move to shake up its menu, Velvet Taco proudly announces the launch of its latest creation, the Velvet Bowls. This fresh offering arrives after a successful "Weekly Bowl Feature" campaign that highlighted the restaurant's adventurous flavors without the need for tortillas. As a taco restaurant renown...
Continue Reading
